ASX - By Stock
|
PER |
Re:
Ann: Update - Proposed issue of securities - ANP
|
|
alakinfitz
|
156 |
49K |
9 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
156
|
49K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Update - Proposed issue of securities - ANP
|
|
alakinfitz
|
156 |
49K |
9 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
156
|
49K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Entitlement Offer Closing Date Extended
|
|
alakinfitz
|
61 |
18K |
3 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
61
|
18K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Webinar TOMORROW 12:30pm Sydney with CEO, Chair & NED!
|
|
alakinfitz
|
110 |
26K |
2 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
110
|
26K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Webinar TOMORROW 12:30pm Sydney with CEO, Chair & NED!
|
|
alakinfitz
|
110 |
26K |
1 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
110
|
26K
|
1
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
alakinfitz
|
855 |
238K |
10 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
238K
|
10
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
alakinfitz
|
855 |
238K |
1 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
238K
|
1
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
alakinfitz
|
855 |
238K |
11 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
238K
|
11
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
alakinfitz
|
855 |
238K |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
238K
|
2
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
alakinfitz
|
855 |
238K |
14 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
238K
|
14
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
alakinfitz
|
855 |
238K |
6 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
238K
|
6
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
alakinfitz
|
855 |
238K |
12 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
238K
|
12
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
alakinfitz
|
855 |
238K |
7 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
238K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
alakinfitz
|
143 |
51K |
28 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
143
|
51K
|
28
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
alakinfitz
|
1.0K |
366K |
15 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
1.0K
|
366K
|
15
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
alakinfitz
|
1.0K |
366K |
1 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
1.0K
|
366K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
alakinfitz
|
1.0K |
366K |
3 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
1.0K
|
366K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
alakinfitz
|
1.0K |
366K |
1 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
1.0K
|
366K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
alakinfitz
|
1.0K |
366K |
0 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
1.0K
|
366K
|
0
|
|
ASX - By Stock
|
ANO |
Re:
Texture and finish of ClearZinc sunscreen
|
|
alakinfitz
|
31 |
12K |
5 |
25/09/21 |
25/09/21 |
ASX - By Stock
|
31
|
12K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: New data supports ATL1102s broader clinical potential
|
|
alakinfitz
|
66 |
24K |
4 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
66
|
24K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD
|
|
alakinfitz
|
174 |
47K |
20 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
174
|
47K
|
20
|
|
ASX - By Stock
|
AVH |
Re:
US hospital use
|
|
alakinfitz
|
74 |
37K |
5 |
24/07/21 |
24/07/21 |
ASX - By Stock
|
74
|
37K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Manufacture of ATL1102 clinical supplies for Phase IIb trial
|
|
alakinfitz
|
41 |
13K |
0 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
41
|
13K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Director Appointment/Resignation
|
|
alakinfitz
|
13 |
3.7K |
0 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
13
|
3.7K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
alakinfitz
|
1.5K |
472K |
6 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
1.5K
|
472K
|
6
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Manufacturing Update
|
|
alakinfitz
|
7 |
2.9K |
1 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
7
|
2.9K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
alakinfitz
|
1.5K |
472K |
2 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.5K
|
472K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
alakinfitz
|
413 |
167K |
2 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
413
|
167K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Chart - Breakout
|
|
alakinfitz
|
9 |
3.0K |
3 |
09/01/21 |
09/01/21 |
ASX - By Stock
|
9
|
3.0K
|
3
|
|
ASX - By Stock
|
PER Medicine |
Re:
ANP breakout
|
|
alakinfitz
|
85 |
33K |
19 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
85
|
33K
|
19
|
|
ASX - By Stock
|
PER |
Re:
Greetings from Europe
|
|
alakinfitz
|
13 |
4.4K |
3 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
13
|
4.4K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP raises A$7.3 million from Oversubscribed Placement
|
|
alakinfitz
|
54 |
13K |
1 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
54
|
13K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
alakinfitz
|
23 |
6.1K |
3 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
23
|
6.1K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
alakinfitz
|
23 |
6.1K |
0 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
23
|
6.1K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to apply for dual listing on Frankfurt Stock Exchange
|
|
alakinfitz
|
25 |
6.1K |
0 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
25
|
6.1K
|
0
|
|
ASX - By Stock
|
PER |
Re:
DMD results
|
|
alakinfitz
|
25 |
6.2K |
3 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
25
|
6.2K
|
3
|
|
ASX - By Stock
|
PER |
Re:
DMD results
|
|
alakinfitz
|
25 |
6.2K |
2 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
25
|
6.2K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Pause in Trading
|
|
alakinfitz
|
97 |
24K |
2 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
97
|
24K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Pause in Trading
|
|
alakinfitz
|
97 |
24K |
0 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
97
|
24K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Pause in Trading
|
|
alakinfitz
|
97 |
24K |
5 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
97
|
24K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Pause in Trading
|
|
alakinfitz
|
97 |
24K |
3 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
97
|
24K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Pause in Trading
|
|
alakinfitz
|
97 |
24K |
2 |
24/10/20 |
24/10/20 |
ASX - By Stock
|
97
|
24K
|
2
|
|
ASX - By Stock
|
PER |
Re:
ODD....DESIGNATED!! here we go!
|
|
alakinfitz
|
25 |
7.2K |
0 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
25
|
7.2K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
alakinfitz
|
8 |
2.4K |
4 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
8
|
2.4K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
alakinfitz
|
8 |
2.4K |
3 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
8
|
2.4K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
alakinfitz
|
8 |
2.4K |
1 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
8
|
2.4K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
alakinfitz
|
8 |
2.4K |
1 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
8
|
2.4K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Grants RPDD to ATL1102 for the treatment of DMD
|
|
alakinfitz
|
109 |
29K |
1 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
109
|
29K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
alakinfitz
|
71 |
23K |
0 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
71
|
23K
|
0
|
|